Skip to Content

7113 (Docusate 250 mg)

This pill with imprint "7113" is Red, Capsule-shape and has been identified as Docusate sodium 250 mg. It is supplied by Watson Pharmaceuticals.

Docusate is used in the treatment of constipation and belongs to the drug class laxatives. FDA has not classified the drug for risk during pregnancy. Docusate 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for 7113

Docusate sodium

Imprint:
7113
Strength:
250 mg
Color:
Red
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Laxatives
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:
FD&C Red No. 40
FD&C Yellow No. 6
gelatin
glycerin
polyethylene glycol
propylene glycol
water
sorbitol
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide